Imaging to optimize liver tumor ablation

Imaging in Medicine

Volumn 2, Issue 4, 2010, Pages 433-443

  Pua, Bradley B ^a   Sofocleous, Constantinos T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

bone scan; CT; MRI; running injury; sports medicine; stress fracture; stress injury

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; MANGAFODIPIR;

ARTIFICIAL EMBOLISM; CANCER SIZE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; HUMAN; IMAGING; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL TECHNIQUE; TUMOR ABLATION;

EID: 77955569900     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.10.32     Document Type: Review

References (60)

1. Lau WY: Primary hepatocellular carcinoma. In: Surgery of the Liver and Biliary Tract (2nd Edition, Vol II). Blumgart LH, Fong Y (Eds). WB Saunders, London, UK, 1423-1450 (2000).
2. Steele G Jr, Ravikumar TS: Resection of hepatic metastasis from colorectal cancer. Biologic perspective. Ann. Surg. 210, 127-138 (1989).
3. Kim YS, Rhim H, Lim HK: Imaging after radiofrequency ablation of hepatic tumors. Semin. Ultrasound CT MRI 30, 49-66 (2009).
4. Goldberg SN, Dupuy DE: Image-guided radiofrequency tumor ablation: challenges and opportunities - Part 1. J. Vasc. Interv. Radiol. 12, 1021-1032 (2001).
5. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ: Diagnostic laparoscopy and laparoscopic ultrasonography optimize staging and resectability of intraabdominal tumors. Surg. Endosc. 15, 1016-1019 (2001).
6. Pearson AS, Francesco I, Fleming RY et al.: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am. J. Surg. 178, 592-599 (1999).
7. Lencioni R, Cioni D, Crocetti L et al.: Early stage hepatocellular carcinoma in patients with cirrhosis: long term results of percutaneous image guided ablation. Radiology 234, 961-967 (2005).
8. Yang W, Chen MH, Yin SS et al.: Radiofrequency ablation of recurrent hepatocellcular carcinoma after hepatectomy: therapeutic efficacy on early and late phase recurrence. AJR Am. J. Roentgenol. 186, S275-S283 (2006).
9. Lau WY, Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma. A systematic review. Ann. Surg. 249, 20-25 (2009).
10. Salmi A, Turrini R, Lanzani G, Savio A, Anglani L: Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis. Int. J. Med. Sci. 5, 327-332 (2008).
11. Chen MS, Li JQ, Zheng Y et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 243, 321-328 (2006).
12. Lu MD, Kuang M, Liang J et al.: Surgical resection versus percutaneous thermal ablation for early stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86, 801-805 (2006).
13. Guglielmi A, Ruzzenente A, Valdegamberi A et al.: Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J. Gastrointest. Surg. 12, 192-198 (2008).
14. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L: Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann. Surg. 242, 158-171 (2005).
15. Lu DS, Raman SS, Limanond P et al.: Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J. Vasc. Interv. Radiol. 14, 1267-1274 (2003).
16. Frieser M, Schaber S, Peters A et al.: Radiofrequency ablation using perfused needle electrodes - study of intermittent and continuous triple needle application ex vivo. Eur. Surg. Res. 37, 312-316 (2005).
17. Lee JM, Han JK, Chang JM et al.: Radiofrequency ablation of the porcine liver in vivo: increased coagulation with an internally cooled perfusion electrode. Acad. Radiol. 13, 343-352 (2006).
18. Ng KK, Lam CM, Poon RT, Shek TW, Fan ST, Wong J: Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein. Br. J. Surg. 91, 632-639 (2004).
19. Kim SH, Lim HK, Choi D et al.: Changes in bile ducts after radiofrequency ablation of hepatocellcular carcinoma: frequency and clinical significance. AJR Am. J. Roentgenol. 183, 1611-1617 (2004).
20. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK: Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann. Surg. 227, 559-565 (1998).
21. Poon RT, Ng KK, Lam CM et al.: Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients at a tertiary institution. Ann. Surg. 239, 441-449 (2004).
22. Hildebrand P, Leinecke T, Kleemann M et al.: Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur. J. Surg. Oncol. 32, 430-434 (2006).
23. Pereira PL, Trubenbach J, Schenk M et al.: Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 232, 482-490 (2004).
24. Ahman A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ: Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am. Surg. 72, 875-879 (2006).
25. Bangard C, Rosgen S, Wahba R et al.: Large-volume multi-tined expandable RF ablation in pig livers: comparison of 2D and volumetric measurements of the ablation zone. Eur. Radiol. 20(5), 1073-1078 (2010).
26. Curley SA: Radiofrequency ablation of malignant liver tumors. Oncologist 6, 14-23 (2001).
27. Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS: Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am. J. Roentgenol. 190, 1544-1551 (2008).
28. Nakazawa T, Kokubu S, Shibuya A et al.: Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am. J. Roentgenol. 188, 480-488 (2007).
29. Lencioni R, Cioni D, Donati F, Bartolozzi C: Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 48, 8-14 (2001).
30. Livraghi T, Goldberg SN, Lazzaroni S et al.: Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214, 761-768 (2000).
31. Wei M, Qiang L, Jian Y, Jie C: Hepatocellular carcinoma fed by the hepatic artery arising from the superior mesenteric artery: angiographic analysis and interventional treatment. Chinese-German J. Clin. Oncol. 2, 176-178 (2003).
32. Miyayama S, Matsui O, Taki K et al.: Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc. Intervent. Radiol. 29, 39-48 (2006).
33. Wang Y, Zhang J, Gao Y, Yu M, Gong Y, Yu G: Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes. Chin. Med. J. 112, 264-268 (1999).
34. Covey AM, Maluccio MA, Schubert J et al.: Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106, 2181-2189 (2006).
35. Malagari K, Pomoni M, Kelekis A et al.: Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc. Intervent. Radiol. 33(3), 541-551 (2010).
36. Kawai S, Okamura J, Ogawa M et al.: Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother. Pharmacol. 31, S1-S6 (1992).
37. Pleguezuelo M, Marelli L, Misseri M et al.: TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev. Anticancer Ther. 8, 1623-1641 (2008).
38. Sugimori K, Nozawa A, Morimoto M: Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J. Vasc. Interv. Radiol. 16, 849-856 (2005).
39. Takaki H, Yamakado K, Uraki J et al.: Radiofrequency ablation combined with chemoembolization for treatment of hepatocellular carcinomas larger than 5cm. J. Vasc. Interv. Radiol. 35, 217-224 (2009).
40. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm. Gastroenterology 127, 1714-1723 (2004).
41. Lencioni RA, Allgaier HP, Cioni D et al.: Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228, 235-240 (2003).
42. Zhang YJ, Liang HH, Chen MS et al.: Hepatocellcular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randoimized trial. Radiology 244, 599-607 (2007).
43. Oliva MR, Saini S: Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging 4, S42-S46 (2004).
44. Kong G, Jackson C, Koh DM et al.: The use of 18F-FDG PET/CT in colorectal liver metastases - comparison with CT and liver MRI. Eur. J. Nucl. Med. Mol. Imaging 35, 1323-1329 (2008).
45. Tsai S, Pawlik TM: Outcomes of ablation versus resection for colorectal liver metastasis: are we comparing apples with oranges? Ann. Surg. Oncol. 16, 2422-2428 (2009).
46. Hur H, Ko YT, Min BS et al.: Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal metastases. Am. J. Surg. 197, 728-736 (2009).
47. Machi J, Osihi AJ, Sumida K et al.: Long term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first and second line management. Cancer 12, 318-326 (2006).
48. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS: Percutaneous ablation of liver metastases in potential candidates for resection. The test of time approach. Cancer 97, 3027-3035 (2003).
49. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M: Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur. Radiol. 17, 1025-1034 (2007).
50. Atassi B, Bangash AK, Bahrani A et al.: Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28, 81-99 (2008).
51. Sofocleous CT, Nascimento RG, Gonen M et al.: Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am. J. Roentgenol. 189, 883-889 (2007).
52. Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr: Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. Radiology 253, 861-869 (2009).
53. Jakobs TF, Hoffmann RT, Schrader A et al.: CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc. Intervent. Radiol. 32, 38-46 (2009).
54. Ohmoto J, Tsuzuki M, Yamamato S: Percutaneous microwave coagulation therapy with intraperitoneal saline infusion for hepatocellular carcinoma in the hepatic dome. AJR Am. J. Roentgenol. 172, 65-66 (1999).
55. Shibata T, Iimuro Y, Ikai I, Hatano E, Yamaoka Y, Konishi J: Percutaneous radiofrequency ablation therapy after intrathoracic saline solution infusion for liver tumor in the hepatic dome. J. Vasc. Interv. Radiol. 13, 313-315 (2002).
56. Rhim H, Lim HK, Kim YS, Choi D: Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am. J. Roentgenol. 190, 91-98 (2008).
57. Hinshaw JL, Laeseke PF, Winter TC III, Kliewer MA, Fine JP, Lee FT Jr: Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am. J. Roentgenol. 186, S306-S310 (2006).
58. Sofocleous CT, Nascimento RG, Petrovic LM et al.: Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 249(1), 364-374 (2008).
59. Goldberg S, Grassi C, Cardella J et al.: Image-guided tumor ablation: Standardization of terminology and reporting criteria. J. Vasc. Interv. Radiol. 20, S377-S390 (2009).
60. Koda M, Ueki M, Maeda Y et al.: The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma. Hepatol. Res. 29, 18-23 (2004). (Pubitemid 38594507)